Related references
Note: Only part of the references are listed.Differential Cell-Protective Function of Two Resveratrol (Trans-3,5,4′-trihydroxystilbene) Glucosides against Oxidative Stress
Ryusuke Hosoda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Sung-Jun Park et al.
CELL (2012)
Clinical trials of resveratrol
Ketan R. Patel et al.
RESVERATROL AND HEALTH (2011)
Cellular and molecular effects of sirtuins in health and disease
Yoshiyuki Horio et al.
CLINICAL SCIENCE (2011)
Resveratrol Ameliorates Muscular Pathology in the Dystrophic mdx Mouse, a Model for Duchenne Muscular Dystrophy
Yusuke S. Hori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice
Jin-Hong Shin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Heart Failure 1 In search of new therapeutic targets and strategies for heart failure: recent advances in basic science
Ajay M. Shah et al.
LANCET (2011)
Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase
Virginia Guarani et al.
NATURE (2011)
Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle
Carles Canto et al.
CELL METABOLISM (2010)
Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure
Masaya Tanno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Sang-Won Min et al.
NEURON (2010)
Myostatin Is Upregulated Following Stress in an Erk-Dependent Manner and Negatively Regulates Cardiomyocyte Growth in Culture and in a Mouse Model
Lawrence T. Bish et al.
PLOS ONE (2010)
FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States
Jongsook Kim Kemper et al.
CELL METABOLISM (2009)
Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300
Jian Qin Wei et al.
CIRCULATION (2008)
Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation
Shin Hisahara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis
Asish K. Ghosh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Resveratrol stimulates AMP kinase activity in neurons
Biplab Dasgupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Ubiquitin-dependent distribution of the transcriptional coactivator p300 in cytoplasmic inclusion bodies
Jihong Chen et al.
EPIGENETICS (2007)
Nucleocytoplasmic shuttling of the NAD+-dependent histone deacrtylase SIRT1
Masaya Tanno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
New approaches in the therapy of cardiomyopathy in muscular dystrophy
Elizabeth M. McNally
ANNUAL REVIEW OF MEDICINE (2007)
Kinetic and mass spectrometric analysis of p300 histone acetyltransferase domain autoacetylation
Balasubramanyam Karanam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Control of cardiac growth by histone acetylation/deacetylation
J Backs et al.
CIRCULATION RESEARCH (2006)
SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1
T Bouras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of the p300 HAT domain via a novel activation loop
PR Thompson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
Cardiac p300 is involved in myocyte growth with decompensated heart failure
T Yanazume et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation
M Eagle et al.
NEUROMUSCULAR DISORDERS (2002)
The transcriptional co-activators CBP and p300 are activated via phenylephrine through the p42/p44 MAPK cascade
R Gusterson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcription
C Poizat et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
GATA-dependent recruitment of MEF2 proteins to target promoters
S Morin et al.
EMBO JOURNAL (2000)
Share Paper
